天宝导航公司 TRMB 深 沪
等待开盘 07-31 09:30:00 美东时间
85.19
+0.500
+0.59%
华盛通- 最 高85.84
- 今 开84.84
- 成交量 254.16万股
- 最 低 84.37
- 昨 收 84.69
- 总市值 203.60亿
- 52周最高 86.42
- 市盈率 静 14.00
- 换手率 1.06%
- 52周最低 51.30
- 委 比 48.12%
- 总股本 2.39亿
- 历史最高 96.487
- 量 比 1.16
- 振 幅 1.74%
- 历史最低 15.90
- 每 手 1
- 风险率 5.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Examining the Future: Teledyne Technologies's Earnings Outlook
Teledyne Technologies (NYSE:TDY) is preparing to release its quarterly earnings...
07-23 01:01
Breaking Down Trimble: 4 Analysts Share Their Views
Trimble (NASDAQ:TRMB) has been analyzed by 4 analysts in the last three months,...
07-17 21:00
美股大行评级 | 巴克莱上调 Robinhood目标价至102美元；瑞银下调京东目标价从58美元至50美元
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从25美元升至29美元；摩根士丹利：维持Legend Biotech"超配"评级，目标价从80美元升至81美元
07-11 09:04
JP Morgan Maintains Overweight on Trimble, Raises Price Target to $95
JP Morgan analyst Tami Zakaria maintains Trimble (NASDAQ:TRMB) with a Overweight and raises the price target from $88 to $95.
07-11 03:47
Bowman to Lead Multi-State Aerial Lidar Work Under U.S. Geological Survey’s 3D Elevation Program
Bowman Consulting Group和Merrick & Company被选中领导飓风Helene受灾地区的空中Lidar数据收集，支持USGS的3D Elevation Program。任务包括覆盖8,800多平方英里的数据采集和处理，由Bowman负责空域收购及数据处理，Merrick负责项目管理和质量控制。Bowman至今已处理超15万平方英里数据，将继续至2026年，预计今年将获得更多任务订单。3DEP数据用于气候适应、基础设施规划及应急响应。
07-10 11:30
AGCO Announces New $1 Billion Share Repurchase Program
DULUTH, Ga., July 9, 2025 /PRNewswire/ -- AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, today announce...
07-10 04:07
A Look Into Trimble Inc's Price Over Earnings
In the current session, the stock is trading at $79.77, after a 0.57% increase....
07-10 04:00
How Is The Market Feeling About Trimble?
Trimble's (NYSE:TRMB) short percent of float has risen 8.3% since its last repo...
06-19 02:00
Price Over Earnings Overview: Trimble
Looking into the current session, Trimble Inc. (NASDAQ:TRMB) shares are trading...
06-14 03:00
Takeda Gains EC Approval For ADCETRIS In Combination With ECADD, Chemotherapy Regimen, In Adult Patients With Newly Diagnosed Stage IIb With Risk Factors/III/IV Hodgkin Lymphoma
- Approval Based on Positive Results from the Phase 3 HD21 Trial for Stage IIb with Risk Factors/III/IV Hodgkin Lymphoma- ADCETRIS-based Combination Demonstrated Superior Safety Profile and Efficacy Compared to eBEACOPP,
06-03 22:14
